Drugs · Brain health technique

GM-CSF (Sargramostim / Leukine®)

Evidence grade: Experimental

Illustration for GM-CSF (Sargramostim / Leukine®)

A recombinant human granulocyte–macrophage colony-stimulating factor (GM-CSF) that stimulates innate immune activity and neuroinflammatory repair mechanisms; marketed as Leukine®, used in oncology and being tested for Alzheimer’s.

Practice
Drugs
Principle
Treatment
Tactic
Neuroprotective & Disease-modifying Therapies
Evidence grade
Experimental
Strength of evidence
Low

How to practice GM-CSF (Sargramostim / Leukine®)

Currently investigational for neurodegenerative use. Administered as subcutaneous injections (typically 250 µg/m² daily for 5 days/week over 3 weeks in trials). Available clinically only for hematologic and transplant indications. Off-label use not recommended outside clinical research due to uncertain safety and optimal dosing for brain health.

The evidence behind GM-CSF (Sargramostim / Leukine®)

GM-CSF is a natural signal that tells your bone marrow to make more white blood cells. Sargramostim is a lab-made version of it. Doctors use sargramostim to help rebuild white blood cell counts after chemotherapy or a bone marrow transplant, which lowers the risk of serious infection.

Impact on brain health

Early clinical trial data in people with mild to moderate Alzheimer's show that sargramostim improved scores on one cognitive assessment and lowered blood markers of tau and nerve cell damage. Researchers think sargramostim works by reactivating microglia and calling in protective immune responses that clear debris and help neurons repair. That mechanism is unproven in people, and the data are still preliminary, from a small group studied for a short time.

Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science

Pair this with other habits from the same practice.

  • Evidence grade: Context Dependent

    Anti-Amyloid Monoclonal Antibodies

    FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

    Medium effort

  • Evidence grade: Context Dependent

    Antihypertensives

    Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

    Low effort · High cost

  • Evidence grade: Context Dependent

    GLP-1 Receptor Agonists

    A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.

See all 20 drugs techniques →

Take control of your brain health

BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.

How BetterBrain worksSee pricing